© 1990 Oxford University Press
other |
Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats
Department of Pathology, University of Maryland, School of Medicine Baltimore, MD 21201, USA
1To whom correspondence should be addressed
We have previously reported that inositol hexaphosphate (InsP6) inhibits mitosis and large intestinal cancer (LIC) in F344 rats and CD1 mice when given as 1 or 2% solution in drinking water at the unadjusted pH of 11.3. The purpose of this study was to determine whether InsP6 (i) shows a dose-response inhibition of LIC, and (ii) retains its anti neoplastic effect at physiological pH. Since InsP6 is known to be a chelator of divalent catiofis, in preparation for putative clinical trials in humans, we also looked at the mineral bioavallability. F344 rats were fed 0.1% (pH 10.8), 1% (pH 11.3) and 1% (pH 7.4) Na-InsP6 in drinking water. Two weeks following the beginning of InsP6 supplementation, rats were given six injections of azoxymethane (AOM) at a dose of 8 mg/kg body wt/week and were killed 30 weeks following the last injection. Compared to the untreated control rats injected with AOM, 1% InsP6 (pH 11.3) reduces tumor prevalence by 52.2% (P < 0.01), tumor frequency by 55.8% (P = 0.001) and tumor size by 62.3% (P = 0.001); 0.1% InsP6 showed a lesser reduction in tumor prevalence (21%) but a greater reduction in tumor size 71% (P = 0.001). While there was no significant difference in tumor prevalence and frequency between the two pH groups, the tumor size following 1% InsP6 (pH 7.4) was the smallest (65% smaller than those of pH 11.3, P < 0.005). There was no significant difference in the serum Mg2+, Ca2+ Fe2+ and Zn2+ level between control rats and those treated with 1% InsP6 We therefore demonstrate that InsP6 (i) is consistently anti neoplastic for LIC in a dose-dependent manner, (ii) retains its anti-neoplastic activity at physiological pH and (iii) has no demonstrable toxic effect on long-term administration as evident by body wt data and serum mineral levels.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Liao, D. N. Seril, A. L. Yang, G. G. Lu, and G.-Y. Yang Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds Carcinogenesis, February 1, 2007; 28(2): 446 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Vucenik, A. Passaniti, M. I. Vitolo, K. Tantivejkul, P. Eggleton, and A. M. Shamsuddin Anti-angiogenic activity of inositol hexaphosphate (IP6) Carcinogenesis, November 1, 2004; 25(11): 2115 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Vucenik and A. M. Shamsuddin Cancer Inhibition by Inositol Hexaphosphate (IP6) and Inositol: From Laboratory to Clinic J. Nutr., November 1, 2003; 133(11): 3778S - 3784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zi, R. P. Singh, and R. Agarwal Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells Carcinogenesis, December 1, 2000; 21(12): 2225 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Reddy, Y. Hirose, L. A. Cohen, B. Simi, I. Cooma, and C. V. Rao Preventive Potential of Wheat Bran Fractions against Experimental Colon Carcinogenesis: Implications for Human Colon Cancer Prevention Cancer Res., September 1, 2000; 60(17): 4792 - 4797. [Abstract] [Full Text]
|
|
|
|
 |
|
 R W Owen, B Spiegelhalder, and H Bartsch Generation of reactive oxygen species by the faecal matrix Gut, February 1, 2000; 46(2): 225 - 232. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Hughes, C. Ganthavorn, and S. Wilson-Sanders Dry Beans Inhibit Azoxymethane-Induced Colon Carcinogenesis in F344 Rats J. Nutr., December 1, 1997; 127(12): 2328 - 2333. [Abstract] [Full Text]
|
|